Down Months: This Market-Crushing Stock Could Be Worth It
A high-quality stock has endured a 19% drop over seven months. This article breaks down how to tell whether the decli...
We compare the 2024 outlook for index funds and target date funds to help you choose the right retirement path.
23,982 articlesA high-quality stock has endured a 19% drop over seven months. This article breaks down how to tell whether the decli...
A federal judge pressed the government over its bid to block Anthropic’s AI from top-secret systems. The hearing unde...
As Alabama lawmakers move toward compromise on utility bills, investors argue that southern company risk looks more m...
The first quarter of 2026 offers clues about corporate health and future growth. This guide explains how to read a go...
Evaxion's Q1 2026 results shed light on how its AI-driven drug discovery model is translating into collaborations and...
When Oshkosh released its latest results, the focus quickly shifted to a sharp stock move. This guide explains what h...
SVB Capital, a 110-person venture arm once tied to SVB Bank, is in limbo after regulators seized the parent bank. A p...
Colgate-Palmolive posted stronger-than-expected Q1 2026 results, setting the stage for upside despite tariff headwind...
Rivian has captured imaginations—and capital. But the next 12 months will test its ability to scale, control costs, a...
Cerebras exploded higher on its debut, but what comes next for investors? This guide breaks down the hype, the fundam...
Pershing Square signals a bold bet by leaning into Microsoft as the AI and cloud wave reshapes enterprise tech. The m...
SpaceX’s IPO filing reveals Elon Musk’s proposed package, a historic grant that vests only if the company reaches a $...